CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation

BACKGROUND: Ulcerative colitis (UC) is a nonspecific inflammatory disease for which medications and therapeutic strategies have only been moderately successful. CBLB502, a toll-like receptor 5 (TLR5) agonist derived from Salmonella flagellin, exhibits anticancer and radioprotective activities via mo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Transl Med
Главные авторы: Xu, Yang, Dong, Hongxia, Ge, Changhui, Gao, Yan, Liu, Haifeng, Li, Weiguang, Zhang, Chenggang
Формат: Artigo
Язык:Inglês
Опубликовано: AME Publishing Company 2016
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5009027/
https://ncbi.nlm.nih.gov/pubmed/27668221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.08.25
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы